AMENDMENT NO.1 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 21st, 2022 • F-Star Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 21st, 2022 Company IndustryThis AMENDMENT NO.1 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is entered into as of November 20, 2022, by and among invoX Pharma Limited, a private limited company under the laws of England and Wales (“Parent”), Fennec Acquisition Incorporated, a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and F-star Therapeutics, Inc., a Delaware corporation (the “Company” and together with Parent and Purchaser, the “Parties”).
AMENDMENT NO.1 TO AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • November 21st, 2022 • F-Star Therapeutics, Inc. • Pharmaceutical preparations
Contract Type FiledNovember 21st, 2022 Company IndustryThis AMENDMENT NO.1 TO AGREEMENT AND PLAN OF MERGER (this “Amendment”) is entered into as of November 20, 2022, by and among invoX Pharma Limited, a private limited company under the laws of England and Wales (“Parent”), Fennec Acquisition Incorporated, a Delaware corporation and a wholly owned subsidiary of Parent (“Purchaser”), and F-star Therapeutics, Inc., a Delaware corporation (the “Company” and together with Parent and Purchaser, the “Parties”).